
Neogen Corporation NEOG
$ 10.36
3.76%
Quarterly report 2025-Q4
added 01-08-2026
Neogen Corporation EV/EBITDA Ratio 2011-2026 | NEOG
Annual EV/EBITDA Ratio Neogen Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 40.3 | 47 | 37.3 | 46.6 | 32.2 | 29.9 | 26.6 | 27.5 | 26.7 | 26.1 | 24.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47 | 24.4 | 33.1 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
27.4 | $ 116.77 | 2.54 % | $ 35.5 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.19 | 1.71 % | $ 6.48 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.96 | 0.52 % | $ 693 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.9 | -0.06 % | $ 481 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Danaher Corporation
DHR
|
20.1 | $ 196.79 | 3.03 % | $ 140 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.91 | -4.44 % | $ 8.45 M | ||
|
Illumina
ILMN
|
70.5 | $ 128.88 | 1.93 % | $ 20.5 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.85 | 1.02 % | $ 951 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-28.8 | $ 93.45 | 0.16 % | $ 11.7 B | ||
|
DexCom
DXCM
|
39.5 | $ 65.61 | 3.96 % | $ 25.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 275.56 | 2.37 % | $ 22.9 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 80.03 | 2.5 % | $ 5.4 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 15.99 | -0.62 % | $ 172 M | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 324.02 | 4.25 % | $ 27.3 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 108.01 | 0.79 % | $ 8.91 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.75 | 0.11 % | $ 440 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Natera
NTRA
|
-19.5 | $ 212.17 | 1.38 % | $ 20.9 B | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.46 | 1.04 % | $ 438 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 27.99 | 3.63 % | $ 20 B | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Personalis
PSNL
|
-7.07 | $ 6.41 | 3.89 % | $ 380 M | ||
|
RadNet
RDNT
|
17.6 | $ 56.08 | 2.75 % | $ 4.22 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 175.71 | 3.64 % | $ 8.71 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.6 | -2.37 % | $ 275 M | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 503.51 | 2.88 % | $ 190 B | ||
|
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 51.68 | 3.11 % | $ 3.09 B | ||
|
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | ||
|
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
-1.8 | $ 27.98 | -1.82 % | $ 44.9 M | ||
|
Waters Corporation
WAT
|
24.6 | $ 320.56 | 4.29 % | $ 19.1 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Exagen
XGN
|
-2.2 | $ 3.08 | 2.5 % | $ 66.4 M |